Read More Pharma Industry News Foresee Pharmaceuticals begins FP-025 phase 2/3 trial in Covid-19 associated ARDS Foresee Pharmaceuticals has started patient dosing in a phase 2/3 trial of FP-025 in adults having severe to… bySrinathMarch 28, 2021
